MONROVIA, CA, March 19, 2009
/24-7PressRelease/ -- Alison Goss Eng, from the United States Department of Energy will be the featured speaker at GTCbio's Inaugural Biofuels: Science and Innovation for Sustainable Development Conference on June 28-30, 2009 in San Francisco, California.
Alison Goss Eng will deliver her featured address entitled "U.S. Department of Energy Biomass Program: Integrated Research Targeting Sustainability Challenges to Promote Industry Growth" at this years Inaugural conference.
Alison Goss Eng is currently the lead for sustainability research and development programming for the Biomass and Bioenergy Program at the United States Department of Energy. She received her PhD from Purdue University in Earth and Atmospheric Sciences, and has a background in terrestrial ecology, hydrogeography and human impacts on water resources. She also currently serves on the Interagency Sustainability Working Group under the Federal Biomass Research and Development Board.
Alison is a member of the U.S. delegation on the Global Bioenergy Partnership's Greenhouse Gas Accounting and Sustainability working groups, and represents the Department of Energy on the Council for Sustainable Biomass Production, a multi-stakeholder group developing biomass to biofuel sustainability principles and standards for the production of feedstocks for second-generation biorefineries. Alison is also representing the U.S. as a lead author on the bioenergy chapter of a new International Panel on Climate Change (IPCC) report on renewable energy and climate change mitigation.
The Inaugural Biofuels: Science and Innovation for Sustainable Development Conference will be held June 28-30, 2009 in San Francisco, Ca. and will include a pre conference workshop titled "How to Accelerate the Commercialization of Biofuels." In addition the conference will also cover such topics as Environmental Sustainability, Economic Sustainability, Biomass Feedstocks and the Sustainability of New Biofuels production and innovative techniques and technologies for Biomass Conversion.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://gtcbio.com/userAgenda.aspx?id=153
About GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
Read more Press Releases from Rania Hafez:- Joost Oppenheim, M.D., Laboratory Chief - NCI, to give Keynote Presentation at GTCbio's 8th Cytokines & Inflammation Conference on January 28-29, 2010 in San Diego, CA
- Vaccines: All Things Considered Conference to be held by GTCbio on November 9-10, 2009 in Washington, DC
- Translational Medicine Track of the GTCbio 5th Annual Modern Drug Discovery & Development Conference to be held on October 14-16, 2009 in San Diego, CA
- Amy Scott-Billman, VP at GlaxoSmithKline to do Keynote at Modern Drug Discovery & Development Summit
- Biological Therapeutics to be an Important Focus at the 5th Modern Drug Discovery & Development Summit held by GTCbio on October 14-16, 2009 in San Diego, CA.
- GTCbio Announces 4th Annual Assay Development and Screening Conference taking place June 8-9, 2009.
- Dr. Joseph Bolen, CSO of Millennium to give Keynote Presentation at GTCbio's 4th Annual Protein Kinases in Drug Discovery Conference taking place on May 4-5, 2009 in Boston, MA
- GTCbio Announces its Inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, Pennsylvania.
- Pete Adamson, Head of Research for Ophthiris at GlaxoSmithKline to give Keynote Presentation at GTCbio's Inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, PA.
- GTCbio Announces its Inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, Pennsylvania.
